Theravance Biopharma shareholders held extraordinary general meeting on merger proposals
Theravance Biopharma held an extraordinary general meeting on Sept. 18, 2026 to vote on merger-related resolutions. The meeting approved a special resolution authorizing the merger agreement and related transaction documents, including the plan of merger. The resolution also authorized amendments to the company’s memor